Stellar Biotechnologies competitorsClear all

Stellar Biotechnologies's top competitors include Alimera Sciences, Biogen and Ironwood Pharmaceuticals.
Stellar Biotechnologies
Stellar Biotechnologies
Stellar Biotechnologies is a biotechnology company.
Alimera Sciences
Alimera Sciences
Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Founding Date
Founding Date
1999
Founding Date
2003
Founding Date
1978
Founding Date
N/A
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Port Hueneme, US HQ
Locations
Alpharetta, US HQ
Berlin, DE
Dublin 2, IE
Lisboa, PT
Hampshire, GB
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Cambridge, US HQ
Boston, US
Employees
Employees
1220% decrease
Employees
1222% decrease
Employees
7,4005% decrease
Employees
31738% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
23.2 m
Valuation ($)
42.2 b
Valuation ($)
1.5 b
Twitter followers
Twitter followers
226
Twitter followers
2.3 k
Twitter followers
34.3 k
Twitter followers
3.6 k
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
344430
Alexa Website Rank
254464
Alexa Website Rank
313890
Employee Rating
Employee Rating
N/A
Employee Rating
3.8
Employee Rating
3.9
Employee Rating
3.9

Financial

Revenue (est.)
Revenue (est.)
$410.9k (FY, 2019)
Revenue (est.)
$53.9m (FY, 2019)
Revenue (est.)
$14.4b (FY, 2019)
Revenue (est.)
$428.4m (FY, 2019)
Cost of goods
Cost of goods
$101.3k (FY, 2019)
Cost of goods
N/A
Cost of goods
$2b (FY, 2019)
Cost of goods
$23.9m (FY, 2019)
Gross profit
Gross profit
$309.6k (FY, 2019)
Gross profit
N/A
Gross profit
$12.4b (FY, 2019)
Gross profit
$404.5m (FY, 2019)
Net income
Net income
($2.8m) (FY, 2019)
Net income
($10.4m) (FY, 2019)
Net income
$5.9b (FY, 2019)
Net income
$21.5m (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 24.3m
Total funding raised
$ 232.6m
Total funding raised
N/A
Total funding raised
$ 609m
For sources of this data, please see the company profile

View company profiles

Alimera Sciences
HQ
Alpharetta, US
Employees
122↓ 2% decrease

Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.

View company
Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
317↓ 38% decrease

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company